ATE373663T1 - Neues verfahren zur herstellung von epothilone- derivaten - Google Patents

Neues verfahren zur herstellung von epothilone- derivaten

Info

Publication number
ATE373663T1
ATE373663T1 AT03748015T AT03748015T ATE373663T1 AT E373663 T1 ATE373663 T1 AT E373663T1 AT 03748015 T AT03748015 T AT 03748015T AT 03748015 T AT03748015 T AT 03748015T AT E373663 T1 ATE373663 T1 AT E373663T1
Authority
AT
Austria
Prior art keywords
new process
epothilone derivatives
producing epothilone
producing
derivatives
Prior art date
Application number
AT03748015T
Other languages
English (en)
Inventor
Guido Koch
Olivier Loiseleur
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9944042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE373663(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE373663T1 publication Critical patent/ATE373663T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT03748015T 2002-09-13 2003-09-12 Neues verfahren zur herstellung von epothilone- derivaten ATE373663T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0221312.2A GB0221312D0 (en) 2002-09-13 2002-09-13 Organic compounds

Publications (1)

Publication Number Publication Date
ATE373663T1 true ATE373663T1 (de) 2007-10-15

Family

ID=9944042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03748015T ATE373663T1 (de) 2002-09-13 2003-09-12 Neues verfahren zur herstellung von epothilone- derivaten

Country Status (29)

Country Link
US (1) US7470792B2 (de)
EP (1) EP1539768B1 (de)
JP (1) JP4628102B2 (de)
KR (1) KR20050042500A (de)
CN (1) CN100522968C (de)
AR (1) AR041231A1 (de)
AT (1) ATE373663T1 (de)
AU (2) AU2003267349B2 (de)
BR (1) BR0314263A (de)
CA (1) CA2497119C (de)
CY (1) CY1107794T1 (de)
DE (1) DE60316456T2 (de)
DK (1) DK1539768T3 (de)
EC (1) ECSP055652A (de)
ES (1) ES2290489T3 (de)
GB (1) GB0221312D0 (de)
IL (1) IL166829A (de)
MX (1) MXPA05002785A (de)
MY (1) MY140442A (de)
NO (1) NO20051794L (de)
NZ (1) NZ538612A (de)
PE (1) PE20050052A1 (de)
PL (1) PL375039A1 (de)
PT (1) PT1539768E (de)
RU (2) RU2343155C2 (de)
SG (1) SG155770A1 (de)
TW (1) TWI289563B (de)
WO (1) WO2004024735A2 (de)
ZA (1) ZA200501008B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242469B1 (en) 1996-12-03 2001-06-05 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
WO2004018478A2 (en) 2002-08-23 2004-03-04 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
CN103037903A (zh) 2010-05-18 2013-04-10 天蓝制药公司 用于治疗自身免疫性疾病或其它疾病的组合物和方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU716610B2 (en) * 1996-08-30 2000-03-02 Novartis Ag Method for producing epothilones, and intermediate products obtained during the production process
US6441186B1 (en) 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
US6380394B1 (en) * 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
EP1201666A3 (de) * 1997-02-25 2003-03-05 Gesellschaft für biotechnologische Forschung mbH (GBF) Seitenkettenmodifizierte Epothilone
US6498257B1 (en) 1998-04-21 2002-12-24 Bristol-Myers Squibb Company 2,3-olefinic epothilone derivatives
GB9810659D0 (en) * 1998-05-18 1998-07-15 Ciba Geigy Ag Organic compounds
AU2795000A (en) * 1998-12-22 2000-07-12 Novartis Ag Epothilone derivatives and their use as antitumor agents
JP2003505459A (ja) * 1999-07-22 2003-02-12 シエーリング アクチエンゲゼルシャフト エポチロンｂおよび誘導体製造のための方法、ならびにこの方法のための中間製品
US6593115B2 (en) * 2000-03-24 2003-07-15 Bristol-Myers Squibb Co. Preparation of epothilone intermediates
AU2002213248A1 (en) * 2000-10-13 2002-04-22 The University Of Mississipi Synthesis of epothilones and relates analogs
WO2004012735A2 (en) * 2002-07-31 2004-02-12 Schering Ag New effector conjugates, process for their production and their pharmaceutical use

Also Published As

Publication number Publication date
JP4628102B2 (ja) 2011-02-09
CA2497119C (en) 2011-08-02
AR041231A1 (es) 2005-05-11
NO20051794D0 (no) 2005-04-12
TW200413388A (en) 2004-08-01
AU2003267349A1 (en) 2004-04-30
ECSP055652A (es) 2005-05-30
CY1107794T1 (el) 2013-06-19
RU2005110925A (ru) 2006-01-20
AU2003267349B2 (en) 2008-05-01
SG155770A1 (en) 2009-10-29
MXPA05002785A (es) 2005-06-03
ES2290489T3 (es) 2008-02-16
TWI289563B (en) 2007-11-11
JP2006511469A (ja) 2006-04-06
PE20050052A1 (es) 2005-03-28
MY140442A (en) 2009-12-31
NO20051794L (no) 2005-04-12
US7470792B2 (en) 2008-12-30
AU2008203451A1 (en) 2008-08-21
CA2497119A1 (en) 2004-03-25
WO2004024735A3 (en) 2004-07-22
EP1539768A2 (de) 2005-06-15
RU2343155C2 (ru) 2009-01-10
RU2404985C2 (ru) 2010-11-27
IL166829A (en) 2011-01-31
RU2008129613A (ru) 2010-01-27
BR0314263A (pt) 2005-07-05
GB0221312D0 (en) 2002-10-23
WO2004024735A2 (en) 2004-03-25
DE60316456D1 (de) 2007-10-31
PL375039A1 (en) 2005-11-14
DE60316456T2 (de) 2008-06-19
KR20050042500A (ko) 2005-05-09
CN100522968C (zh) 2009-08-05
NZ538612A (en) 2008-01-31
PT1539768E (pt) 2007-12-17
DK1539768T3 (da) 2008-01-07
HK1078853A1 (en) 2006-03-24
CN1681824A (zh) 2005-10-12
US20060106073A1 (en) 2006-05-18
EP1539768B1 (de) 2007-09-19
ZA200501008B (en) 2006-12-27

Similar Documents

Publication Publication Date Title
DE602004023921D1 (de) Neues verfahren zur herstellung vonroflumilast
DE502004001613D1 (de) Verfahren zur herstellung von polyamiden
DE502004009768D1 (de) Verfahren zur herstellung von dreiwertigen organophosphor-verbindungen
ATE414077T1 (de) Verfahren zur herstellung von 1-ä(benzimidazol-1- yl)chinolin-8-ylüpiperidin-4-ylaminderivaten
DE60324813D1 (de) Verfahren zur Herstellung von Wellenleitern
DE602004020895D1 (de) Verfahren zur herstellung von kohlenstoffnanospulen
DE50308650D1 (de) Verfahren zur herstellung von cellulosecarbamatformkörpern
ATE448209T1 (de) Verfahren zur herstellung von pyrimidinverbindungen
ATE456569T1 (de) Verfahren zur herstellung von 6-alkyliden- penemderivaten
ATE376997T1 (de) Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
ATE453619T1 (de) Verfahren zur herstellung von hydroperoxiden
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
DE602004021605D1 (de) Verfahren zur herstellung von enantiomerenreinem mirtazapin
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
DE502004007419D1 (de) Verfahren zur Herstellung von Radschüsseln
DE60314113D1 (de) Verfahren zur herstellung von phenylorganosiliciumzwischenprodukten
ATE371642T1 (de) Verfahren zur herstellung von 3- methylthiopropanal
ATE471941T1 (de) Verfahren zur herstellung von thiazolopyrimidinen
DE502004002810D1 (de) Verfahren zur herstellung von copolymerisaten
DE602004001646D1 (de) Verfahren zur Herstellung von Pyran
DE602004031740D1 (de) Verfahren zur herstellung von konzentraten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1539768

Country of ref document: EP